Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
Samarth Hegde, Varintra E. Krisnawan, Brett H. Herzog, et al.
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 289-307.e9
Open Access | Times Cited: 362

Showing 26-50 of 362 citing articles:

Localization, tissue biology and T cell state — implications for cancer immunotherapy
Jason M. Schenkel, Kristen E. Pauken
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 807-823
Open Access | Times Cited: 62
Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis
Miles Piper, Maureen Hoen, Laurel B. Darragh, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 950-969.e6
Open Access | Times Cited: 48
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer
Jad I. Belle, D. Sen, John Baer, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1324-1355
Closed Access | Times Cited: 19
Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer
Krishnan K. Mahadevan, Allison M. Dyevoich, Yang Chen, et al.
Science (2024) Vol. 384, Iss. 6703
Closed Access | Times Cited: 17
Cross-priming in cancer immunology and immunotherapy
Carlos Luri‐Rey, Álvaro Teijeira, Stefanie K. Wculek, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 3
Dendritic cell maturation in cancer
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s
Takaaki Oba, Mark D. Long, Tibor Keler, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 115
Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance
Varintra E. Krisnawan, Jennifer Stanley, Julie K. Schwarz, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2916-2916
Open Access | Times Cited: 87
The biological underpinnings of therapeutic resistance in pancreatic cancer
Gregory L. Beatty, Gregor Werba, Costas A. Lyssiotis, et al.
Genes & Development (2021) Vol. 35, Iss. 13-14, pp. 940-962
Open Access | Times Cited: 87
Metabolic programming in dendritic cells tailors immune responses and homeostasis
Sofie Hedlund Møller, Limei Wang, Ping‐Chih Ho
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 3, pp. 370-383
Open Access | Times Cited: 83
Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies
Jaewon J. Lee, Vincent Bernard, Alexander Semaan, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 21, pp. 5912-5921
Open Access | Times Cited: 83
Autophagy, the innate immune response and cancer
Chelsea Gerada, Kevin M. Ryan
Molecular Oncology (2020) Vol. 14, Iss. 9, pp. 1913-1929
Open Access | Times Cited: 81
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma
Erin F. Simonds, Edbert D Lu, O. Badillo, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 6, pp. e002181-e002181
Open Access | Times Cited: 72
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
Utpreksha Vaish, Tejeshwar Jain, Abhi C. Are, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13408-13408
Open Access | Times Cited: 67
Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
William W. Ho, Igor L. Gomes‐Santos, Shuichi Aoki, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 45
Open Access | Times Cited: 64
Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade
Varintra E. Lander, Jad I. Belle, Natalie L. Kingston, et al.
Cancer Discovery (2022) Vol. 12, Iss. 12, pp. 2774-2799
Open Access | Times Cited: 64
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, et al.
Cellular Oncology (2022) Vol. 46, Iss. 1, pp. 17-48
Closed Access | Times Cited: 58
Modeling pancreatic cancer in mice for experimental therapeutics
Kavita Mallya, Shailendra K. Gautam, Abhijit Aithal, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188554-188554
Open Access | Times Cited: 57
Facts and Hopes in Immunotherapy of Pancreatic Cancer
Bruno Bockorny, Joseph E. Grossman, Manuel Hidalgo
Clinical Cancer Research (2022) Vol. 28, Iss. 21, pp. 4606-4617
Closed Access | Times Cited: 57
Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy
Ze Mi, Qing Yao, Yan Qi, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 819-833
Open Access | Times Cited: 51
Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer
Hongyi Chen, Qin Guo, Yongchao Chu, et al.
Biomaterials (2022) Vol. 287, pp. 121599-121599
Closed Access | Times Cited: 46
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
André E. Nel, Kuo‐Ching Mei, Yu‐Pei Liao, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 5184-5232
Open Access | Times Cited: 45

Scroll to top